Cargando…
Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in mice
BACKGROUND: Probiotics have beneficial effects in rodent models of Clostridium difficile (C. diffiicle)-induced colitis. The spore forming probiotic strain Bacillus Coagulans GBI-30, 6086 (BC30) has demonstrated anti-inflammatory and immune-modulating effects in vitro. Our goal was to determine if B...
Autores principales: | Fitzpatrick, Leo R, Small, Jeffrey S, Greene, Wallace H, Karpa, Kelly D, Keller, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212889/ https://www.ncbi.nlm.nih.gov/pubmed/22014083 http://dx.doi.org/10.1186/1757-4749-3-16 |
Ejemplares similares
-
Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice
por: Fitzpatrick, Leo R, et al.
Publicado: (2012) -
Probiotic Bacillus coagulans GBI-30, 6086 Improves Protein Absorption and Utilization
por: Jäger, Ralf, et al.
Publicado: (2017) -
Bacillus coagulans GBI-30, 6086 improves amino acid absorption from milk protein
por: Stecker, Richard A., et al.
Publicado: (2020) -
Inactivated probiotic Bacillus coagulans GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro
por: Jensen, Gitte S, et al.
Publicado: (2017) -
Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery
por: Jäger, Ralf, et al.
Publicado: (2016)